Bixue Xu
State Key Laboratory Of Discovery And Utilization Of Functional Components In Traditional Chinese Medicine
Guiyang, 550000, China
Guiyang, 550000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
BLM as a potential therapeutic target in cutaneous malignant melanoma.
Journal: Biochemical pharmacology
Published: March 18, 2026
Structure-optimized 4-trifluoromethylquinoline derivatives: Dual enhancement of SGK1 inhibition and anti-prostate cancer efficacy.
Journal: Bioorganic chemistry
Published: February 26, 2026
A trifluoromethyl quinazoline inhibits hepatocellular carcinoma proliferation through HDAC1 binding and multi-target mechanisms.
Journal: iScience
Published: February 25, 2026
Design, synthesis, and anti-prostate cancer activity evaluation of novel thieno[2,3-b]pyridine derivatives as potential BLM helicase inhibitors.
Journal: Molecular diversity
Published: February 14, 2026
Hijacking the Hydrogen Sulfide Axis: A Novel 4-Trifluoromethylquinoline Derivative Suppresses Glioblastoma via Cystathionine γ-Lyase Suppression.
Journal: Journal of medicinal chemistry
Published: February 03, 2026
A Trifluoromethyl Quinazoline Compound Regulates the Epithelial-Mesenchymal Transition of Prostatic Hyperplasia Cells by Inhibiting the Secretion of TGF-β1 in Stromal Cells.
Journal: Current issues in molecular biology
Published: November 20, 2025
A trifluoromethyl quinoline derivative targets SGK1 and modulates the PI3K/AKT pathway to inhibit prostate cancer progression.
Journal: Medical oncology (Northwood, London, England)
Published: September 28, 2025
The fluoroquinoline compound exerts anti-erythroleukemic effects by dual-targeting GLUT1 and the PI3K/AKT signaling pathway.
Journal: Scientific reports
Published: September 25, 2025
Novel trifluoromethylquinoline derivatives as potent tubulin polymerization inhibitors with antitumor activity.
Journal: Bioorganic & medicinal chemistry
Published: August 07, 2025
Correction: Discovery of novel 4-trifluoromethyl-2-anilinoquinoline derivatives as potential anti-cancer agents targeting SGK1.
Journal: Molecular diversity
Published: April 29, 2025
Quinazoline Derivative kzl052 Suppresses Prostate Cancer by Targeting WRN Helicase to Stabilize DNA Replication Forks.
Journal: International journal of molecular sciences
Published: April 23, 2025
Last Updated: 09/26/2026